Abstract
DNA repair systems are essential for normal cell function. Genetic alterations in the DNA repair genes such as X-ray repair cross-complementing group 3 (XRCC3), can cause a change in protein activity which results in cancer susceptibility. The aim of this study was to investigate the association of XRCC3 Thr241Met single nucleotide polymorphism (SNP), smoking and alcohol consumption with the risk of laryngeal cancer in Turkish population. The frequencies of Thr241Met SNP were studied in 58 laryngeal cancer cases (SSC) and 67 healthy individuals. Genomic DNA was isolated from peripheral blood samples of both controls and laryngeal cancer cases. Thr241Met SNP was genotyped by polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) method. The genotype and allele frequencies of Thr241Met polymorphism were not statistically significant between the laryngeal cancer and control groups. Carrying mutant allele was not associated with the risk of laryngeal cancer. On the other hand, smoking and chronic alcohol consumption were associated with the risk of laryngeal cancer but there is no association between Thr241Met, smoking and alcohol consumption in laryngeal cancer cases. These results indicate that Thr241Met polymorphism was not associated with the development of laryngeal cancer in Turkish population. However, it should be kept in mind that the association of a polymorphism with cancer susceptibility can differ due to several factors such as cancer type, selection criteria, ethnic differences and size of the studied population.
Similar content being viewed by others
References
Clayman GL, Lippman SM, Laramore GF et al (2000) Neoplasms of the head and neck. Cancer medicine, 5th edn. BC Becker Inc., New York (section 27)
Annual report on the rare diseases and conditions research. National Institutes of Health. Retrieved 2007-03-22
New cancer diagnoses for 2009. BC Cancer Agency. Retrieved 2012-01-06
SEER Stst Fact Sheets: Larynx cancer. NCI. Retrived 18 June 2014
Genden EM, Ferlito A, Silver CE, Jacobson AS, Werner JA, Suárez C, Leemans CR, Bradley PJ, Rinaldo A (2007) Evolution of the management of laryngeal cancer. Oral Oncol 43:431–439. doi:10.1016/j.oraloncology.2006.08.007
Cancer-throat or larynx, MedlinePlus Medical Encyclopedia
Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16:481–488. doi:10.1093/annonc/mdi098
Austin DF, Reynolds P (1996) Laryngeal cancer. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemology and prevention. Oxford University Press, New York
Blot WJ, McLaughlin JK, Devesa SS, Fraumeni JF (1996) Cancers are the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemology and prevention. Oxford University Press, New York
Huang WY, Olshan AF, Schwartz SM, Berndt SI, Chen C, Llaca V, Chanock SJ, Fraumeni JF Jr, Hayes RB (2005) Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemol Biomarkers Prev 14:1747–1753. doi:10.1158/1055-9965.EPI-05-0162
Mohrenweiser HW, Wilson DM 3rd, Jones IM (2003) Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 526:93–125. doi:10.1016/S0027-5107(03)00049-6
Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q (1998) Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemol Biomarkers Prev 2:465–468
Hu JJ, Mohrenweiser HW, Bell DA, Leadon SA, Miller MS (2002) Symposium overview: genetic polymorphisms in DNA repair and cancer risk. Toxicol Appl Pharmacol 285:64–73. doi:10.1006/taap.2002.9518
Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27:247–254. doi:10.1038/85798
Brenneman MA, Weiss AE, Nickoloff JA, Chen DJ (2000) XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. Mutat Res 459:89–97. doi:10.1016/S0921-8777(00)00002-1
Bishop DK, Ear U, Bhattacharyya A, Calderone C, Beckett M, Weichselbaum RR, Shinohara A (1998) XRCC3 is required for assembly of Rad51 complexes in vivo. J Biol Chem 273:21482–21488. doi:10.1074/jbc.273.34.21482
Forget AL, Bennett BT, Knight KL (2004) XRCC3 is required to DNA double strand breaks early and independent of Rad51. J Cell Biochem 93:429–436. doi:10.1002/jcb.20232
Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L (2008) Natural selection has driven population differentiation in modern humans. Nat Genet 40:340–345. doi:10.1038/ng.78
Shen MR, Jones IM, Mohrenweiser H (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58:604–608
Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano E, Krogh V, Munnia A, Tumino R, Polidoro S, Piazza A, Vineis P (2001) XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32) p-DNA adducts in a sample of healthy subjects. Carcinogenesis 22:1437–1445. doi:10.1093/carcin/22.9.1437
He XF, Wei W, Li JJ, Shen XL, Ding DP, Wang SL, Liu ZZ, Qin JB, Wu LX, Xie DL (2013) Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies. Gene 523:10–19. doi:10.1016/j.gene.2013.03.071
Zhan P, Wang Q, Qian Q, Yu LK (2013) XRCC3 Thr241 Met gene polymorphisms and lung cancer risk: a meta-analysis. J Exp Clin Cancer Res 32:1. doi:10.1186/1756-9966-32-1
Wang Z, Zhang W (2013) Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk. Tumour Biol 34:1421–1429. doi:10.1007/s13277-012-0639-1
Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435–7451. doi:10.1038/sj.onc.1205803
Brooks PJ (1997) DNA damage, DNA repair, and alcohol toxicity-a review. Alcohol Clin Exp Res 21:1073–1082. doi:10.1111/j.1530-0277.1997.tb04256.x
Thacker J, Zdzienicka MZ (2004) The XRCC genes: expanding roles in DNA double-strand break repair. DNA Repair 3:1081–1090. doi:10.1016/j.dnarep.2004.04.012
Han S, Zhang HT, Wang Z, Xie Y, Tang R, Mao Y, Li Y (2006) DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur J Hum Genet 14:1136–1144. doi:10.1038/sj.ejhg.5201681
Sliwinski T, Walczak A, Przybylowska K, Rusin P, Pietruszewska W, Zielinska-Blizniewska H, Olszewski J, Morawiec-Sztandera A, Jendrzejczyk S, Mlynarski W, Majsterek I (2010) Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in Polish population. Exp Mol Pathol 89:358–366. doi:10.1016/j.yexmp.2010.08.005
Mucha B, Przbylowska-Sygut K, Dzıkı AJ, Dzıkı L, Sygut A, Majsterek I (2013) Association of Thr241Met polymorphism of XRCC3 gene with risk of colorectal cancer in the polish population. Pol J Pathol 64:185–190. doi:10.5114/pjp.2013.38137
David-Beabes GL, Lunn RM, London SJ (2001) No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 10:911–912
Stern MC, Umbach DM, Lunn RM, Taylor JA (2002) DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:939–943
Bănescu C, Tilinca M, Benedek EL, Demian S, Macarie I, Duicu C, Dobreanu M (2013) XRCC3 THr241Met polymorphism and risk of acute myeloid leukemia in a Romanian population. Gene 526:478–483. doi:10.1016/j.gene.2013.05.054
Sorour A, Ayad MW, Kassem H (2013) The genotype distribution of the XRCC1, XRCC3 and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarkers 17:195–201. doi:10.1089/gtmb.2012.027
Zhao B, Ye J, Li B, Ma Q, Su G, Han R (2013) DNA repair gene XRCC3 Thr241Met polymorphism and glioma risk: a meta-analysis. Int J Clin Exp Med 6:438–443 ISSN:1940-5901/IJCEM1305003
Dos Reis MB, Losi-Guembarovski R, de Souza Fonseca Ribeiro EM, Cavalli IJ, Morita MC, Ramos GH, de Oliveira BV, Mizuno LT, Rogatto SR, de Syllos Cólus IM (2013) Allelic variants of XRCC1 and XRCC3 repair genes and susceptibility of oral cancer in Brazilian patients. J Oral Pathol Med 42:80–85. doi:10.1111/j.1600-0714.2012.01192.x
Yin QH, Liu C, Li L, Zu XY, Wang YJ (2012) Association between the XRCC3 T241M polymorphism and head and neck cancer susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev 13:5201–5205
Wen SX, Zhang XM, Tang PZ, Zhao D, Guo YL, Tan W, Lin DX (2007) Association between genetic polymorphism in DNA repair genes XRCC3 and risks of laryngeal and hypolaryngeal carcinomas. Zhongjua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 42:856–859
Li D, You HH, Jia YJ, Guo JD, Du HL (2014) Association of C722T polymorphism in XRCC3 gene with larynx cancer: a meta-analysis. Tumour Biol 35:5427–5430. doi:10.1007/s13277-014-1707-5
Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A (2004) DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 112:901–904. doi:10.1002/ijc.20474
Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H (2004) Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidermiol Biomarkers Prev 13:583–591
Shen H, Sturgis EM, Dahlstrom KR, Zheng Y, Spitz MR, Wei Q (2002) A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer 99:869–872. doi:10.1002/ijc.10413
Matullo G, Guarrera S, Sacerdote C, Polidoro S, Davico L, Gamberini S, Karagas M, Casetta G, Rolle L, Piazza A, Vineis P (2005) Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 14:2569–2578
Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P, Porru S (2003) Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 12:1234–1240
Conflict of interest
This study was supported by Dışkapı Yıldırım Beyazıt Training and Research Hospital BAP Foundation (# 41/3). The authors of this study declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mutlu, P., Mutlu, M., Yalçın, S. et al. Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population. Eur Arch Otorhinolaryngol 272, 3779–3784 (2015). https://doi.org/10.1007/s00405-014-3435-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3435-2